AU3942193A - Transdermal albuterol absorption dosage unit and process - Google Patents
Transdermal albuterol absorption dosage unit and processInfo
- Publication number
- AU3942193A AU3942193A AU39421/93A AU3942193A AU3942193A AU 3942193 A AU3942193 A AU 3942193A AU 39421/93 A AU39421/93 A AU 39421/93A AU 3942193 A AU3942193 A AU 3942193A AU 3942193 A AU3942193 A AU 3942193A
- Authority
- AU
- Australia
- Prior art keywords
- dosage unit
- absorption dosage
- transdermal albuterol
- albuterol
- transdermal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86120692A | 1992-03-31 | 1992-03-31 | |
US861206 | 1997-05-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3942193A true AU3942193A (en) | 1993-11-08 |
Family
ID=25335173
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU39421/93A Abandoned AU3942193A (en) | 1992-03-31 | 1993-03-31 | Transdermal albuterol absorption dosage unit and process |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3942193A (en) |
WO (1) | WO1993019708A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0524959D0 (en) * | 2005-12-07 | 2006-01-18 | Pharmakodex Ltd | Topical compositions for treatment of respiratory disorders |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0184910B1 (en) * | 1984-11-15 | 1992-09-30 | Hercon Laboratories Corporation | Device for controlled release drug delivery |
DE3729299A1 (en) * | 1987-09-02 | 1989-03-23 | Beiersdorf Ag | TRANSDERMAL THERAPEUTIC SYSTEM |
-
1993
- 1993-03-31 AU AU39421/93A patent/AU3942193A/en not_active Abandoned
- 1993-03-31 WO PCT/US1993/003013 patent/WO1993019708A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1993019708A1 (en) | 1993-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6374594A (en) | Process and device for atomizing liquids | |
AU4522693A (en) | Structural fumigation process and apparatus | |
GB2276639B (en) | Solutions for wood treatment and their preparation | |
AU7237394A (en) | Morphinan derivative and medicinal use | |
AU6480994A (en) | Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration | |
AU4315889A (en) | Granule application device and process | |
AU6160594A (en) | Diabetes prevention and treatment | |
AU4520893A (en) | Sterilization process and composition | |
AU5067193A (en) | Pyranoquinolines and their use as pharmaceuticals | |
GB2268439B (en) | Pipe-welding device and process | |
IL109340A0 (en) | A transdermal system containing pilocarpine and a process for the preparation thereof | |
AU4100593A (en) | Iminoalcohol-oxazolidine mixtures and their use | |
AU1191892A (en) | Isoprene process and catalysts therefor | |
SG46724A1 (en) | Use of granisetron for the treatment of post operative nausea and vomittung | |
AU3942193A (en) | Transdermal albuterol absorption dosage unit and process | |
AU2294192A (en) | Transdermal nicotine absorption dosage unit and process | |
AU3526193A (en) | Dosage aerosols containing the active substance flezelastin and related structures | |
AU5284593A (en) | Liquid treatment apparatus | |
AU4825993A (en) | New compounds for use in the treatment of cancer | |
AU1587295A (en) | The treatment of gaseous substances | |
EP0553611A3 (en) | Process and container for the treatment of must | |
HU9403797D0 (en) | New analgesic and nootropic drugs | |
AU5165993A (en) | Pp14-based therapy | |
AU4365593A (en) | Unit for treating liquid | |
AU3674893A (en) | Sensitizer and use |